Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Reverse Transcriptase Polymerase Chain Reaction × Clear all

NCT00389805 2018-10-31

Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Phase 1/2 Completed

27 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms